The DOI matches its OpenAlex record.
Evaluating new vaccines for developing countries. Efficacy or effectiveness?
Abstract
Despite the profusion of promising new vaccines against illnesses prevalent in developing countries, uncertainties about the balance between costs and benefits of new vaccines have retarded their use in public health practice. Conventional prelicensure trials of vaccine protection exacerbate these uncertainties by focusing on measurement of vaccine efficacy--the performance of a vaccine under idealized conditions. Vaccine effectiveness trials provide a more pragmatic perspective by addressing the performance of a vaccine under the ordinary conditions of a public health program, by capturing direct as well as indirect effects of vaccination, and by comprehensively addressing outcomes of public health concern. The use of effectiveness trials should enable more rational triaging of new vaccines for developing countries and may accelerate the introduction of new vaccines into public health practice by resolving speculative debates about practical costs and benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cattaneo, A., Davanzo, R., Worku, B., Surjono, A., Echeverria, M., Bedri, A., Haksari, E., Osorno, L., Gudetta, B., Setyowireni, D., et al. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb01769.x · Cited by 243
Verani, J. R., Baqui, A. H., Broome, C. V., Cherian, T., Cohen, C., Farrar, J. L., Feikin, D. R., Groome, M. J., Hajjeh, R. A., Johnson, H. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.037 · Cited by 102
“Once vaccines are introduced into public health programs, their performance under ‘‘real world” conditions also needs assessment [1], including among populations with subgroups that may have been excluded from pre-licensure trials (e.”
BackgroundBrooker, S., Bethony, J. M., Rodrigues, L. C., Alexander, N., Geiger, S. M., & Hotez, P. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.1.35 · Cited by 40
Metadata
- Authors
- Clemens, J. D.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1996-02-07
- Volume
- 275
- Issue
- 5
- Pages
- 390-397
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4244549969
- Cited by
- 165
- References
- 0
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluating new vaccines for developing countries. Efficacy or effectiveness? https://app.cochat.ai/papers/10.1001/jama.275.5.390
- The paper
- Clemens, J. D. (1996). Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA. https://doi.org/10.1001/jama.275.5.390
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.